Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP542955.RAY6YUXNuStyanv3dA_yFgdrPfwHVoi1RcR61wcH-3wy0130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542955.RAY6YUXNuStyanv3dA_yFgdrPfwHVoi1RcR61wcH-3wy0130_provenance.
• NP655280.RATOIqrdDhLDBEOXqEdJvErmlfqhcw84jJ5_bFiN-UbMw130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655280.RATOIqrdDhLDBEOXqEdJvErmlfqhcw84jJ5_bFiN-UbMw130_provenance.
• assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP783170.RAMLZd1fMikenWv23OkbV6t50DESpwVpoAPE0ROGbXzLo130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783170.RAMLZd1fMikenWv23OkbV6t50DESpwVpoAPE0ROGbXzLo130_provenance.
• NP616944.RACTOfNHGTCIjwNVUHO_jtf3xlcU_ASbCpgIyiCqdv_9I130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616944.RACTOfNHGTCIjwNVUHO_jtf3xlcU_ASbCpgIyiCqdv_9I130_provenance.
• NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447529.RAmXoS5Y83n_xMYh5Bx8DyJp5ydCxMz_lfvyVafqOsG7Y130_provenance.
• NP616946.RAgI6dnmUkCXRwPwb7u5B_bM-Y_GzdCDcUKnzMjXUMToE130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616946.RAgI6dnmUkCXRwPwb7u5B_bM-Y_GzdCDcUKnzMjXUMToE130_provenance.
• NP496770.RA_EopOiPoKHScNvx7Ahzr_KoSUODfwC-LV2evMlBQp5U130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496770.RA_EopOiPoKHScNvx7Ahzr_KoSUODfwC-LV2evMlBQp5U130_provenance.
• NP616943.RAL-BJgGSX7Dsyvm260QaUDXBscJbqC1CZO5R16nLbOVI130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616943.RAL-BJgGSX7Dsyvm260QaUDXBscJbqC1CZO5R16nLbOVI130_provenance.
• NP707360.RA4yNTE46bUqBdx6oD_HB8NDcr_gHXB55UYyQlQ1KmWCg130_assertion description "[Our aim was to determine the expression of c-Met, its ligand hepatocyte growth factor/scatter factor (HGF/SF) and Her2/neu in ductal carcinoma in situ (DCIS) lesions of the breast (n = 39) by two different immunocytochemical techniques, classical immunohistochemistry and immunofluorescence, and to correlate their expression levels with histopathological and clinical characteristics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707360.RA4yNTE46bUqBdx6oD_HB8NDcr_gHXB55UYyQlQ1KmWCg130_provenance.